TROY BUTAPHOSPHAN INJECTION

Šalis: Australija

kalba: anglų

Šaltinis: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Veiklioji medžiaga:

BUTAPHOSPHAN; VITAMIN B12 = CYANOCOBALAMIN

Prieinama:

TROY LABORATORIES PTY LTD

INN (Tarptautinis Pavadinimas):

butaphosphan(100mg/mL)+cyanocobalamin(50ug/mL)

Vaisto forma:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Sudėtis:

BUTAPHOSPHAN UNGROUPED Active 100.0 mg/ml; VITAMIN B12 = CYANOCOBALAMIN VITAMIN-B12 Active 50.0 ug/ml

Vienetai pakuotėje:

100mL

Klasė:

VM - Veterinary Medicine

Pagaminta:

TROY LABORATORIES

Farmakoterapinė grupė:

CALF | CAT | CATTLE | DOG | GOAT | HORSE | HORSE FOAL | LAMB | PIG | PIGS - SEE LABEL FOR TYPE | SHEEP | BEEF | BEEF CALF | BIL

Gydymo sritis:

NUTRITION & METABOLISM

Terapinės indikacijos:

PHOSPHORUS SUPPLEMENT | VITAMIN B12 SUPPLEMENT

Produkto santrauka:

Poison schedule: 0; Withholding period: WITHHOLDING PERIODS Meat: Animal may b e slaughtered for human consumption at any time after treatment. Milk: Milk may be collected or processed for huma n consumption at any time after treatme nt. TRADE ADVICE: EXPORT SLAUGHTER IN TERVAL (ESI): Animals may be slaughtere d for export at any time after treatme nt.; Host/pest details: CALF: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; CAT: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; CATTLE: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; DOG: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; GOAT: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; HORSE: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; HORSE FOAL: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; LAMB: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; PIG: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; PIGS - SEE LABEL FOR TYPE: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; SHEEP: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; Poison schedule: 0; Withholding period: ; Host/pest details: CALF: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; CAT: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; CATTLE: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; DOG: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; GOAT: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; HORSE: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; HORSE FOAL: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; LAMB: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; PIG: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; PIGS - SEE LABEL FOR TYPE: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; SHEEP: [PHOSPHORUS SUPPLEMENT, VITAMIN B12 SUPPLEMENT]; For phosphorus and vitamin B12 supplementation of animals.

Autorizacija statusas:

Registered

Leidimo data:

2023-07-01

Pakuotės lapelis

Immediate Label
TROY BUTAPHOSPHAN INJECTION
12.07.2012
Front Panel:
FOR ANIMAL TREATMENT ONLY
TROY BUTAPHOSPHAN INJECTION
Active Constituents:
100mg/mL BUTAPHOSPHAN
50pg/mL CYANOCOBALAWN (Vitamin
B
12
)
For phosphorus and vitamin
B12
supplementation of animals.
100ML
Ancillary Panels:
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE
FOR USE ONLY BY OR UNDER THE DIRECTION OF A REGISTERED VETERINARY
SURGEON.
•
RLP
Approved
DOSAGE AND ADMINISTRATION:
ONCE BROACHED, THE PRODUCT MUST BE USED WITHIN 90 DAYS. DISCARD ANY
UNUSED PORTION.
FOR
I.M. or S.C. injection according to the enclosed directions for use.
Sterile technique and
equipment must be used for each injection.
In acutely diseased animals:
Horse, Cattle
5 — 25mL
Foal, Calf
5 — 12mL
Sheep, Goat
2.5 — 5rnL
Lamb '
1.5 — 2.5mL
Pig
2.5 — 10mL
•
Suckling_ Pig
1.0 — 2.5mL
'
Dog
0.5 — 5mL
Cat
0.5 — 5mL
Repeat daily if required.
In cases of chronic disease use half of the above stated dosage at
intervals of 1 — 2 weeks or less.
In healthy animals administer half of the above dose.
WITHHOLDING PERIODS
MEAT: ANIMALS MAY BE SLAUGHTERED FOR HUMAN CONSUMPTION AT ANY TIME
AFTER TREATMENT.
MILK:
MILK MAY BE COLLECTED OR PROCESSED FOR HUMAN CONSUMPTION AT ANY TIME
AFTER TREATMENT.
TRADE ADVICE: EXPORT SLAUGHTER INTERVAL (ESI):
Animals may be slaughtered for export at any
time after treatment.
FIRST AID
If poisoning occurs, contact a doctor or Poisons Information Centre.
Phone Australia 13 11 26.
STORAGE:
Store below 30°C (Room Temperature). Store upright and protected from
light.
DISPOSAL
—
Dispose of empty container by wrapping with paper and putting in
garbage.
TROY LABORATORIES PTY. LIMITED
31-35 GLENDENNING ROAD, GLENDENNING NSW 2761
APVMA:
66214153004
Batch:
Expiry:
LI[XXXX]
Troy Laboratories Pty Limited
Page 1 of 1
Infopest
Verified
Carton Label
TROY BUTAPHOSPHAN INJECTION
12.07.2012
Front/Rear Panel:
FOR ANIMAL TREATMENT ONLY
TROY BUTAPHOSPHAN INJECTION
Active Constituents:
100mg/mL BUTAPHOSPHAN
50pg/mL CYANOCOBALAMIN (Vi

Prekės savybės

SAFETY DATA SHEET
PRODUCT NAME: TROY BUTAPHOSPHAN INJECTION
PAGE: 1 OF 4
THIS REVISION ISSUED: AUGUST, 2012
SAFETY DATA SHEET
Issued by: Troy Laboratories Australia Pty Ltd
Phone: [phone]
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
TROY LABORATORIES AUSTRALIA PTY. LTD ABN: 21 000 283 769
TEL:
[phone]
31-35 GLENDENNING ROAD
FAX:
[phone]
GLENDENNING NSW 2761
CHEMICAL NATURE:
Water solution of ingredients.
TRADE NAME:
TROY BUTAPHOSPHAN INJECTION
APVMA CODE:
66214
PRODUCT USE:
Phosphorus and vitamin B
12
supplement for animals.
CREATION DATE:
AUGUST, 2012
THIS VERSION ISSUED:
AUGUST, 2012
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S25. Avoid contact with eyes.
SUSMP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: Clear, pink solution, free of lint, dirt and all visible particle
matter.
ODOUR:
No data re odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
POTENTIAL HEALTH EFFECTS
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomfort in
normal use.
LONG TERM EXPOSURE:
No data for health effects associated with long term skin exposure.
EYE CONTACT:
SH